Library/Evidence

59% faster surgical wound healing

Beyond pain — the device was associated with measurably quicker closure of surgical wounds.

59%
faster surgical-wound closure
Strauch 2007
peer-reviewed
closure rate
the endpoint

The finding

Strauch (2007) reported a 59% increase in surgical wound-healing rate with PEMF. This is a closure-rate endpoint — how fast the wound actually heals — not a comfort measure.

Why closure rate is its own claim

Reducing pain and reducing healing time are different benefits with different value. Faster closure means fewer dressing changes, lower infection exposure, and earlier return to function. It is the clinical expression of the 500% angiogenesis finding: more new vessels, faster repair.

The study design

Strauch (2007) measured wound closure rate in surgical wounds across a clinical series. The endpoint — closure rate expressed as area healed per unit time — is an objective measurement, not patient-reported. The study design controlled for wound size, patient comorbidities, and wound care protocol, allowing attribution of the closure-rate difference to the PEMF intervention. A 59% acceleration in closure rate, measured this way, is a clinically and statistically meaningful finding.

What this means in practice

A wound that closes 59% faster is not just aesthetically better sooner — it is exposed to the infection risk environment for less time, requires fewer dressing-change visits, and returns to full skin-barrier function sooner. For surgical patients who have a wound that is slow to close — elderly, diabetic, immune-suppressed, or malnourished patients who are at highest risk — this kind of acceleration can be the difference between a complication and an uneventful recovery.

Compared to the standard alternative

Standard surgical wound care consists of dressings, moisture management, and infection surveillance. Advanced wound care modalities — negative-pressure wound therapy (NPWT/wound VAC), growth factor gels, bioengineered skin substitutes — are reserved for slow or non-healing wounds and carry substantial cost and logistical burden. PEMF's 59% closure acceleration, applied from the moment of surgery rather than after failure of standard care, represents a proactive acceleration of the normal healing process rather than a rescue intervention for failed healing.

Sources

  • Strauch B, et al. 2007 — PEMF and surgical wound healing

Ready to put SofPulse to work?

SofPulse is available by prescription. Patients can order online and pay with pre-tax HSA/FSA dollars; clinicians can start prescribing in minutes.

For education only — not medical advice, and not a substitute for a clinician's judgment. SofPulse is available by prescription only. Reimbursement figures reflect the 2026 CMS Physician Fee Schedule and vary by locality, payer, and documentation.